The intelligent promotion project of pharmaceutical company was listed in the "new intelligent manufacturing" benchmark enterprise cultivation library.
Release time:
2021-12-23
"new intelligent building " enterprise cultivation library project of Jinhua economic and technological development zone, and was officially included in the benchmark enterprise cultivation library of the future factory "new intelligent building " of the development zone in 2021 . "New Wisdom Building
"Project is a project carried out by Jinhua Economic and Technological Development Zone to implement the deployment requirements of digital reform in Zhejiang Province, establish and improve the promotion mechanism, accelerate the deep integration of new generation information technology and manufacturing industry, effectively stimulate the vitality of innovation and development, create a new manufacturing group led by "Future Factory " , and promote the transformation and upgrading of traditional industries. The enterprises participating in the declaration should be industrial enterprises registered and established in the development zone according to law. The application project should have the characteristics of advanced technology, great market potential, strong demonstration and driving effect, and strong industry representation. It can be recommended or declared by the township (street). The Economic Development Bureau of the Development Zone will set up and review the cultivation projects, The key cultivation projects are classified and cultivated according to the future factory, intelligent factory and digital workshop. Successful enterprises shall organize and implement pilot tasks according to the requirements, carry out the task of gathering intelligence and gathering strength to tackle key problems and create tasks. After the completion of the project implementation, they shall conduct assessment and acceptance according to the requirements of the acceptance evaluation index system. The project declared by the pharmaceutical company this time is intelligent production. The main body of the project will fully implement
DCS/SISsystem in the bulk drug workshop of Jinxi Base. Implement BMS/EMS system in clean workshop, build SCADA system and quality review and analysis system, and optimize the existing MES system, at the same time, the construction of integrated management and control platform integration to enhance the existing security and human vehicle management system. After the implementation of this project, the operation cost can be reduced. Through the implementation of automatic control, the control of reaction conditions can be more accurate, the conversion rate of materials can be improved, and the amount of waste generated can not only reduce the production cost, but also reduce the environmental protection treatment cost. The product development cycle is shortened, which is conducive to the compliance trial production of clinical samples, the high automation of chemical process and the real-time recording of parameters, and the authenticity of process data are ensured, it is conducive to the determination of various process parameters in the research and development stage and will greatly speed up the progress of product research and development. It is conducive to scientific control, scientific allocation of production factors through setting production scheduling plan, equipment management, SCADA system production whole process monitoring, etc., and comprehensively reduces the labor cost of enterprise production and management through automatic, intelligent and systematic production management. At the same time, it provides various auxiliary reports and provides data support for decision-making for management. The implementation of DCS and SIS systems can improve the degree of production automation, reduce on-site operators, meet the high-end requirements of industry safety supervision, and reduce potential production hidden dangers and various safety hidden dangers through real-time monitoring of production links, alarm of abnormal production points, and fire control of the whole plant, thus significantly improving the guarantee level of enterprise production safety. In the process of process production, the control of automatic system is fully guaranteed, which avoids the mistakes and deviations of human operation to the greatest extent. Through the monitoring and statistical analysis of production energy consumption, the energy consumption of standard products and industry energy consumption is matched, and the potential of energy saving is tapped, which is conducive to reducing the energy consumption of production, thus reducing the production cost of enterprises. It is understood that the project will be implemented on the basis of planning and detailing each module, and the installation and debugging of
DCS, SIS , BMS and EMS systems will be completed in the later period. Other modules will be timely carried out according to the overall progress requirements, and the overall operation of SCADA system will be finally completed, project acceptance is planned for the fourth quarter of 2022 . (Yu Xun Song Shijie)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page